The 1Florida ADRC is a consortium of Florida institutions — Mount Sinai Medical Center, UF, FAU, FIU and the University of Miami. Their team evaluates people with and without memory disorders and other thinking problems for diagnosis and participation in research studies. Under the supervision of the FDA, they test new medicines to research their effectiveness on Alzheimer’s disease.
BRAIN Center researchers are focused on cutting-edge science in neuroresilience and the development of new diagnostic and therapeutic strategies for brain injury.
The BREATHE Center’s mission is to create a world-renowned program devoted to understanding physiological challenges to respiratory motor control in health and disease, and to translate our knowledge into strategies of respiratory rehabilitation in devastating clinical disorders that compromise breathing.
Addiction and related disorders represent a significant threat to individuals, families and their communities. It is only through the collaborative efforts of diverse programmatic research that we can understand the contributing processes and define more effective prevention, intervention and recovery programs.
The center provides centralized and state of the art transdisciplinary diagnostic and clinical treatment services for children and adults with neurodevelopmental disorders.
The CAM’s mission is to conduct interdisciplinary clinical neuroscience and translational research on age-associated cognitive, behavioral and emotional functioning, factors that contribute to impairments and functional decline, and future avenues for intervention.
The CNG integrates molecular, genetic and clinical approaches to define the causes of neurodegenerative disease and develop effective treatment strategies.
Over 30 percent of adults and adolescents have experienced an anxiety disorder at some time in their lives. COARD is an interdisciplinary group of researchers and clinicians who conduct clinical and translational research in obsessive compulsive and anxiety disorders.
The UFCST is organized as a University-wide center to coordinate and promote basic and applied research and education in the chemical senses across traditional academic boundaries. The UFCST applies this broad knowledge base to create a unique opportunity to advance discovery, application, and education in the chemical senses that can serve the state, the Southeast, and the nation.
The CTRND is a multi-disciplinary research center focused on the discovery, development and evaluation of future treatments and diagnostics for degenerative central nervous system conditions including Alzheimer’s disease, ALS, frontotemporal lobar degeneration, Parkinson’s disease and stroke.
The mission of the CTSI is to improve human health by accelerating the translation of scientific discoveries and the implementation of evidence-based best practices for the diagnosis, treatment, prevention and cure of human disease.
The primary research mission of the UFGI is to promote and enhance interactive genetics research across the UF campus. The UFGI is built on a foundation of outstanding genetics research programs already in existence across UF in such diverse fields as medicine, agriculture, chemistry and engineering.
The mission of the Institute on Aging is to improve the health, independence and quality of life of older adults by means of interdisciplinary teams in the areas of research, education and health care.
The Fixel Institute is home to scientists and clinicians working on neurological disorders that afflict millions of people across the globe. These conditions include Parkinson’s, dystonia and other movement disorders, Alzheimer’s and dementias, concussion, TBI and neuromuscular disorders like ALS.
The Preston A. Wells, Jr. Center is the hub for some of the brightest minds in the fields of neuro-oncology, neurosurgery and radiation oncology. Leading researchers and their teams collaborate with physicians who have dedicated their entire careers to finding a cure for brain cancer.
The mission of the UFHCC is to prevent, detect, treat and ultimately cure cancer while addressing the unique challenges of the cancer burden faced by the population we serve.
Certified by The Joint Commission due to advanced imaging capabilities, 24/7 availability of specialized treatments and staff with unique education and competency standards, the stroke center also boasts a robust research component, including an array of clinical trials available to patients.